Market Place
Sourcing Support
Qiagen Announces Form 20-F Annual Report Filing For 2025 Results
20 Mar 2026 //
PHARMIWEB
QIAGEN Showcases Data Backing Quantiferon`s TB Prevention
19 Mar 2026 //
PHARMIWEB
QIAGEN Receives U.S. Clearance For Gastrointestinal Panels
11 Mar 2026 //
BUSSINESSWIRE
QIAGEN Exceeds Q4 2025 Outlook Driven By Growth Pillars
04 Feb 2026 //
BUSINESSWIRE
QIAGEN Unveils Qiasprint Connect System At SLAS 2026
03 Feb 2026 //
BUSINESSWIRE
QIAGEN Appoints Mark Stevenson To Supervisory Board
26 Jan 2026 //
BUSINESSWIRE
QIAGEN N.V. To Release Results For Q4 2025 And Hold Webcast
19 Jan 2026 //
BUSINESSWIRE
QIAGEN Sets 2026 Priorities to Drive Growth Across Five Units
12 Jan 2026 //
PHARMIWEB
QIAGEN Completes $500M Synthetic Share Repurchase
18 Dec 2025 //
BUSINESSWIRE
QIAGEN Partners With Pharma For CTC Research Advancement
18 Nov 2025 //
PHARMIWEB
Qiagen Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target
04 Nov 2025 //
BUSINESSWIRE
QIAGEN Marks 4,000th QIAcube Connect Placement
28 Oct 2025 //
BUSINESSWIRE
QIAGEN N.V. To Release Results For Q3 2025 And Hold Webcast
13 Oct 2025 //
PHARMIWEB
QIAGEN Earns CE-IVDR Certification for QIAstat-Dx Portfolio in EU
10 Sep 2025 //
PHARMAWEB
Qiagen Sets Conversion Price for New Net Share Convertible Bonds
29 Aug 2025 //
PHARMAWEB
QIAGEN Announces Successful Placement of New Bonds
28 Aug 2025 //
BUSINESSWIRE
QIAGEN Sets Conversion Price of New Convertible Bonds
28 Aug 2025 //
BUSINESSWIRE
QIAGEN Surpasses Q2 2025 Outlook with Robust Growth
05 Aug 2025 //
BUSINESSWIRE
QIAGEN Launches QIAseq xHYB Long Read Panels, Expands Portfolio
22 Jul 2025 //
BUSINESSWIRE
QIAGEN Elects Stephen Rusckowski as Chairman
26 Jun 2025 //
BUSINESSWIRE
Qiagen, Incyte Team Up on MPN Companion Diagnostics
15 Jun 2025 //
BUSINESSWIRE
QIAGEN to Propose Annual Cash Dividend at Shareholder Meeting
07 May 2025 //
BUSINESSWIRE
Qiagen exceeds Q1 2025 outlook, plans dividend, $500 mn repurchas
07 May 2025 //
BUSINESSWIRE
QIAGEN plans leadership transition in Supervisory Board
07 May 2025 //
BUSINESSWIRE
QIAGEN Enhances Cancer Genomic Profiling at AACR 2025
22 Apr 2025 //
BUSINESSWIRE
Qiagen to Launch Three New Sample Prep Instruments by 2026
15 Apr 2025 //
BUSINESSWIRE
Qiagen to Release Results for Q1 2025 and Hold Webcast
08 Apr 2025 //
BUSINESSWIRE
Qiagen Gets US Nod For Second QIAstat-Dx GI Panel
06 Mar 2025 //
BUSINESSWIRE
QIAGEN Defends QuantiFERON IP in Latent TB Testing
03 Mar 2025 //
BUSINESSWIRE
QIAGEN Details $300M Synthetic Share Repurchase Completion Plan
16 Jan 2025 //
BUSINESSWIRE
Qiagen To Return $300M To Shareholders Via Share Repurchase
12 Jan 2025 //
BUSINESSWIRE
Diagnostics firm Qiagen reports rise in third-quarter revenue
07 Nov 2024 //
REUTERS
Qiagen Delivers Solid Q3 2024 Growth, Increases EPS Outlook
06 Nov 2024 //
GLOBENEWSWIRE
Qiagen Leads Global TB Summit 2024 As Disease Reemerges
08 Oct 2024 //
GLOBENEWSWIRE
QIAGEN Launches QIAcuityDx Digital PCR System For Oncology
30 Sep 2024 //
GLOBENEWSWIRE
QIAGEN And Bio-Manguinhos Partner For Malaria And Dengue Detection
12 Sep 2024 //
GLOBENEWSWIRE
QIAGEN N.V. launches non-US offering of net share settled convertible bonds
03 Sep 2024 //
GLOBENEWSWIRE
QIAGEN Announces Successful Placement of New Convertible Bonds
03 Sep 2024 //
GLOBENEWSWIRE
QIAGEN Announces Conversion Price for New Convertible Bonds
03 Sep 2024 //
GLOBENEWSWIRE
QIAGEN Expands QIAstat-Dx Into Precision Medicine For Chronic Diseases
28 Aug 2024 //
GLOBENEWSWIRE
QIAGEN delivers solid performance and exceeds outlook for Q2 2024
31 Jul 2024 //
GLOBENEWSWIRE
QIAGEN N.V. to release results for Q2 2024 and hold webcast
02 Jul 2024 //
GLOBENEWSWIRE
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB in tuberculosis
27 Jun 2024 //
GLOBENEWSWIRE
QIAGEN Announces 2028 Strategy For Solid Profitable Growth
17 Jun 2024 //
GLOBENEWSWIRE
QIAGEN Publishes 2023 Sustainability Report On ESG Progress
12 Jun 2024 //
GLOBENEWSWIRE
QIAGEN To Discontinue NeuMoDx PCR System, Support Customer Transition
06 Jun 2024 //
GLOBENEWSWIRE
QIAGEN: Digital PCR Assay Tool For QIAcuity, GeneGlobe Customization
05 Jun 2024 //
GLOBENEWSWIRE
QIAGEN Expands Gastrointestinal Syndromic Test Menu In US
03 Jun 2024 //
GLOBENEWSWIRE
QIAGEN Gets European IVDR Certification For Clinical Decision Support Software
14 May 2024 //
GLOBENEWSWIRE
US FDA clears Qiagen’s QIAstat-Dx respiratory syndromic testing panel
14 May 2024 //
PHARMABIZ
QIAGEN Gets FDA Clearance For Respiratory Syndromic Testing Panel
13 May 2024 //
GLOBENEWSWIRE
QIAGEN Partners with FBI on Digital PCR Assay for Forensics
06 May 2024 //
GLOBENEWSWIRE
QIAGEN Q1 2024 Results Ahead of Outlook, Tracking FY2024 Guidance
29 Apr 2024 //
GLOBENEWSWIRE
QIAGEN Expands TB Portfolio with New NGS Panel
24 Apr 2024 //
GLOBENEWSWIRE
QIAGEN N.V. to Release Results for Q1 2024 and Hold Webcast
09 Apr 2024 //
GLOBENEWSWIRE
QIAGEN strengthens its portfolio, showcasing latest product at AACR
03 Apr 2024 //
GLOBENEWSWIRE
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access
25 Mar 2024 //
GLOBENEWSWIRE
QIAGEN partners with International Panel Physicians Association to increase
18 Mar 2024 //
GLOBENEWSWIRE
QIAGEN partners with Physicians to increase awareness of tuberculosis
18 Mar 2024 //
GLOBENEWSWIRE
QIAGEN announces Form 20-F annual report filing for 2023 results
11 Mar 2024 //
GLOBENEWSWIRE
